Global Peptide Drug Conjugate Market USD 1400 Million Opportunity Says Kuick Research In New Study. Delhi, June 05, 2025 ...

This finding implicates that targeting PCNA/AR interaction could be an innovative strategy for therapy against CRPC."BUFFALO, ...

The latest edition of "Column Watch" features our annual review of new liquid chromatography columns and accessories, ...

Molecular machine learning (ML) underpins critical workflows in drug discovery, material science, and catalyst optimization ...

This week, LCGC International published a variety of articles on the latest happenings from ASMS 2025. Below, we’ve highlighted some of the most popular articles that were published this week. Agilent ...

This study presents compelling evidence that the denitrosylase SCoR2 regulates cardioprotective metabolic reprogramming in the heart following ischemia/reperfusion injury. The findings are supported ...

This useful manuscript describes cryo-EM structures of archaeal proteasomes that reveal insights into how occupancy of binding pockets on the 20S protease regulates proteasome gating. The evidence ...

Tsingke Biotech recently participated in TIDES USA 2025, the leading international event for oligonucleotide and peptide therapeutics, held in San Diego from May 19 to 22. As a repeat exhibitor, ...

The global neuroendocrine carcinoma treatment market is likely to generate revenue amounting to USD 1,976 million in 2024. Over the assessment period, the industry is projected to expand at an 8.1% ...

The Seattle-based company came to ASCO25 with new data on its neuroendocrine tumor–treating lead therapy, with big vibes and ...

Biocon's share price saw an uptick following key regulatory approvals in India for its Liraglutide drug, which is used in the ...